Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.Journal of neuroscience methods · 2026-11-01Single-crystal structure determination of psilocybin after dehydrationActa Crystallographica Section C Structural Chemistry · 2026-09-01Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Distinct response of resting-state brain networks to psilocybin in autismmedRxiv · 2026-08-22Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.CNS drugs · 2026-08-13Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.CNS drugs · 2026-08-07Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.Pharmacological research · 2026-08-06The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.The International journal on drug policy · 2026-08-01Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorderJournal of Psychopharmacology · 2026-07-16Psilocybin's effect on human brain synaptic plasticity.Translational psychiatry · 2026-07-15Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment OutcomesResearch Square · 2026-06-19DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in ZebrafishMolecules · 2026-06-18Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-17Alcohol consumption and substance use among French medical students: A nationwide cross-sectional study: Consommation d'alcool et de substances chez les étudiants en médecine de France: une étude transversale nationale.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2026-06-09Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-03A Molecule-Resolved Bibliometric Analysis of PubMed-Indexed Psychedelic Research (2015-2025): Volume, Temporal Trends, and Publication TypesEuropean Psychiatry · 2026-06-01Human brain changes after first psilocybin useNature Communications · 2026-05-05Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled TrialClinicalTrials.gov · 2026-05-01Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal CortexhBiological Psychiatry · 2026-05-01Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.Journal of affective disorders · 2026-05-01Associations between psychedelic use and migraine history in Swedish twins.Journal of psychopharmacology (Oxford, England) · 2026-05-01Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome.Chembiochem: a European journal of chemical biology · 2026-04-28Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.Current issues in molecular biology · 2026-04-18Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivitybioRxiv · 2026-04-13Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-09An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.Expert opinion on pharmacotherapy · 2026-04-01Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybinbioRxiv · 2026-03-04Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.Psychedelic medicine (New Rochelle, N.Y.) · 2026-03-01Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.Research square · 2026-02-12Compassionate use of psilocybin for treatment-resistant depression in Germany.The lancet. Psychiatry · 2026-02-01The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-25Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Journal of affective disorders · 2026-01-15Behavioral effects of psychedelic and non-psychedelic serotonin 2A receptor agonist drugs in pigsNeuroscience Applied · 2026-01-01Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adultsNeuroscience Applied · 2026-01-01Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic peopleNeuroscience Applied · 2026-01-01The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trialNeuroscience Applied · 2026-01-01Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adultsNeuroscience Applied · 2026-01-01The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis.Journal of clinical psychopharmacology · 2026-01-01Metastability of resting-state bold fMRI as a reliable biomarker of individual brain dynamics: An interrogation of within-subject variability as a function of total acquisition time.Network neuroscience (Cambridge, Mass.) · 2026-01-01Evolution and horizontal transfer of the psilocybin biosynthetic gene cluster drive the diversification of magic mushroomsMycosphere · 2025-12-25A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-23Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.Harm reduction journal · 2025-11-25Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experiencePsychedelics · 2025-11-20Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological RestorationAdvance · 2025-11-17Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are requiredDrugs & Therapy Perspectives · 2025-11-04Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.Acta neuropsychiatrica · 2025-11-04Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.Translational psychiatry · 2025-10-31Psilocybin-assisted psychotherapy in adults with depression - A literature review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2025-10-01Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.Psychiatry research · 2025-10-01Dynamic myocardial injury and variable hallucination latency in poisoning: a molecularly confirmed case series from China.Clinical toxicology (Philadelphia, Pa.) · 2025-10-01Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.Acta neuropsychiatrica · 2025-09-03Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2025-09-01Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.Translational psychiatry · 2025-08-29Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.Medical science monitor: international medical journal of experimental and clinical research · 2025-08-09The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of PsilocinACS Pharmacology & Translational Science · 2025-08-08631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTSThe international journal of neuropsychopharmacology · 2025-08-01476. ACUTE AND CHRONIC PSILOCYBIN IN MOUSE MODELS OF PSYCHIATRIC DISORDERSThe international journal of neuropsychopharmacology · 2025-08-01204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDERThe International Journal of Neuropsychopharmacology · 2025-07-31Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.Psychiatry and clinical psychopharmacology · 2025-07-30Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome.Chembiochem: a European journal of chemical biology · 2025-07-11Molecular, haemodynamic and functional effects of LSD in the human brainmedRxiv · 2025-06-18The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses.Translational psychiatry · 2025-06-16In vitro assessment of psilocin for CYP-dependent drug-drug interaction potential using rapid luminescent assaysDrug Metabolism and Pharmacokinetics · 2025-06-01Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.Neuroscience and biobehavioral reviews · 2025-06-01In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025-05-22ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT receptors in mouse models of chronic pain.Pharmacological research · 2025-05-01Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025-04-01LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.Pharmaceuticals (Basel, Switzerland) · 2025-03-23Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.The Journal of clinical psychiatry · 2025-03-03The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01Elucidating the Phase I metabolism of psilocin in vitroArchives of Toxicology · 2025-03-01Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.Cancer medicine · 2025-03-01Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases.International journal of behavioral medicine · 2025-02-01Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.Expert review of neurotherapeutics · 2025-02-01Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.Current pain and headache reports · 2025-01-16Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT receptor activation and psychedelic-like activity.European journal of medicinal chemistry · 2025-01-05Mushroom bioactives-polysaccharides to psilocybin: a viewpoint on the therapeutic use of mushrooms for consumers and patients for health and neuroplasticityTranslational Food Sciences · 2025-01-01Psychedelic Medicine Exceptionalism.The American journal of bioethics: AJOB · 2025-01-01Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample.Frontiers in pharmacology · 2025-01-01Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.Journal of clinical psychopharmacology · 2025-01-01Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Therapeutic advances in psychopharmacology · 2025-01-01Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.AJOB empirical bioethics · 2025-01-01Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls.Scientific reports · 2024-12-31Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.JAMA psychiatry · 2024-12-01The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.Journal of psychiatric research · 2024-12-01Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-07“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybinJournal of Psychedelic Studies · 2024-10-29Human brain changes after first psilocybin usebioRxiv · 2024-10-14Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates the gabapentin-mediated analgesiaResearch Square · 2024-09-20Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report.Clinical case reports · 2024-09-01Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.Molecular psychiatry · 2024-07-01Mechanisms of therapeutic change after psychedelic treatment in OCD.Psychiatry research · 2024-06-01Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.Trials · 2024-05-21Inhibition of cytochrome P450 3A4 enzyme activity by alkaloid psilocin from magic mushrooms: potential for drug interactionsDrug Metabolism and Pharmacokinetics · 2024-04-01Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS)Journal of Forensic Sciences · 2024-03-01CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.Journal of addiction psychiatry · 2024-01-01Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.Neuropsychiatric disease and treatment · 2024-01-01Keeping the promise: a critique of the current state of microdosing research.Frontiers in psychiatry · 2024-01-01Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists.AJOB neuroscience · 2024-01-01Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators.Frontiers in pharmacology · 2024-01-01Palliative care patients' attitudes and openness towards psilocybin-assisted psychotherapy for existential distress.Frontiers in psychiatry · 2024-01-01Psilocybin for the treatment of Alzheimer's disease.Frontiers in neuroscience · 2024-01-01Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.Psychiatric research and clinical practice · 2024-01-01Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use.Journal of psychoactive drugs · 2024-01-01Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.Headache · 2024-01-01Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue.Life (Basel, Switzerland) · 2023-12-15Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation studyJournal of Molecular Liquids · 2023-11-07A "Magic Mushroom" Multi-Product Sesquiterpene Synthase.Chembiochem: a European journal of chemical biology · 2023-11-02Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.Molecular psychiatry · 2023-09-01Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells.Current issues in molecular biology · 2023-08-15Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom ExtractResearch Square · 2023-07-20Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant DepressionEuropean psychiatry: the journal of the Association of European Psychiatrists · 2023-07-19Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative studyPsyArXiv · 2023-06-30Psychedelics reopen the social reward learning critical periodNature · 2023-06-13Global species diversity and distribution of the psychedelic fungal genus.Heliyon · 2023-06-01Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.Nature neuroscience · 2023-06-01Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autismmedRxiv · 2023-05-26The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey.Medicina (Kaunas, Lithuania) · 2023-05-09Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.Molecules (Basel, Switzerland) · 2023-03-14Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signalingCNS Neuroscience & Therapeutics · 2023-03-01Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs.Veterinary and animal science · 2023-03-01Acute psilocybin enhances cognitive flexibility in rats.bioRxiv: the preprint server for biology · 2023-01-09Therapeutic effect of psilocybin in addiction: A systematic review.Frontiers in psychiatry · 2023-01-01Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.Frontiers in psychiatry · 2023-01-01Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.Frontiers in psychiatry · 2023-01-01Psilocybin for Depression: From Credibility to Feasibility, What's Missing?Pharmaceuticals (Basel, Switzerland) · 2022-12-31Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.3 Biotech · 2022-12-01Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.Heliyon · 2022-12-01Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Psychedelic drugs for psychiatric disorders.Journal of the neurological sciences · 2022-09-15Psychedelics for Alzheimer's Disease Palliative Care.Advances in psychiatry and behavioral health · 2022-09-01Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-08-01Genetic Survey of Psilocybe Natural Products.Chembiochem: a European journal of chemical biology · 2022-07-19Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivitymedRxiv · 2022-07-10Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.Neuroscience and biobehavioral reviews · 2022-07-01How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.Psychopharmacology · 2022-06-01The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.Systematic reviews · 2022-05-05The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.Journal of midwifery & women's health · 2022-05-01Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.Journal of fungi (Basel, Switzerland) · 2022-03-11Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendeesmedRxiv · 2022-03-02Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory miceTranslational Psychiatry · 2022-02-23Genomic Analysis of Reveals Its Nutritional Strategy and Application Potential in Bioremediation.Journal of fungi (Basel, Switzerland) · 2022-02-06Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.Cureus · 2022-02-01Exploratory review of psilocybin usage and awareness amongst college students and potential consumer goods tradeoffs resulting from increased usageInternational Journal of Research in Marketing Management and Sales · 2022-01-01The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience applied · 2022-01-01Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.Frontiers in psychology · 2022-01-01Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.Frontiers in psychiatry · 2022-01-01Psilocybin modulation of dynamic functional connectivity is associated with plasma psilocin and subjective effectsmedRxiv · 2021-12-17Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.The Australian and New Zealand journal of psychiatry · 2021-12-01Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science advances · 2021-11-19Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational psychiatry · 2021-11-08Analysis of Five Mushroom Toxins in Blood by UPLC-HRMS.Fa yi xue za zhi · 2021-10-25Rediscovering Psilocybin as an Antidepressive Treatment Strategy.Pharmaceuticals (Basel, Switzerland) · 2021-09-28Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.Cells · 2021-07-27Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin.Journal of psychopharmacology (Oxford, England) · 2021-04-01Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.Psychopharmacology · 2021-02-01H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?Frontiers in psychiatry · 2021-01-01P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experienceEuropean Neuropsychopharmacology · 2020-11-01S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in "Magic" Mushrooms.Chembiochem: a European journal of chemical biology · 2020-05-04Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortexbioRxiv · 2020-05-03Psilocybin-assisted therapy for depression: How do we advance the field?The Australian and New Zealand journal of psychiatry · 2020-03-01P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low dosesEuropean Neuropsychopharmacology · 2019-12-01Replication and extension of a model predicting response to psilocybin.Psychopharmacology · 2019-11-01Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.Acta neuropsychiatrica · 2019-08-01Microcrystal Tests for the Identification of Illicit Drugs: Phencyclidine, Pseudoephedrine, and PsilocinThe Microscope · 2019-01-01Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being.Journal of psychoactive drugs · 2019-01-01Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humansEuropean Neuropsychopharmacology · 2019-01-01Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevanceDrug Metabolism Reviews · 2017-01-02Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Journal of psychopharmacology (Oxford, England) · 2016-12-01Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The international journal of neuropsychopharmacology · 2016-07-01Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes.Persoonia · 2015-06-01Recreational use, analysis and toxicity of tryptamines.Current neuropharmacology · 2015-01-01Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs.Natural product reports · 2014-07-01Potential Therapeutic Effects of Psilocybin/Psilocin are Minimized While Possible Adverse Reactions are OverratedTherapeutic Drug Monitoring · 2014-02-01Fungal Hallucinogens Psilocin, Ibotenic Acid, and MuscimolTherapeutic Drug Monitoring · 2013-08-01Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.PloS one · 2013-01-01Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiologyThe FASEB Journal · 2012-04-01Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-GlucuronosyltransferasesDrug Metabolism and Disposition · 2010-03-01Identification of a serotonin/glutamate receptor complex implicated in psychosis.Nature · 2008-03-06SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist.Bioorganic & medicinal chemistry letters · 2005-10-15P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosisEuropean Neuropsychopharmacology · 2003-10-01Drugs of abuse monitoring in blood for control of driving under the influence of drugs.Therapeutic drug monitoring · 2002-04-01What geometric visual hallucinations tell us about the visual cortex.Neural computation · 2002-03-01[Intoxications by hallucinogenic mushrooms].Annales de medecine interne · 2000-10-01Hallucinogenic drugs attenuate the subjective response to alcohol in humans.Human psychopharmacology · 2000-10-01Neurotropic Effect of Extracts from the Hallucinogenic Mushroom Psilocybe cubensis (Earle) Sing. (Agaricomycetideae). In Vitro StudiesInternational journal of medicinal mushrooms · 2000-01-01